winner, winner

Rice scientist receives $2 million award for research on 'new type of fuel'

Rice University's László Kürti has been researching a molecule known as N4 that releases large amounts of energy. Photo by Jeff Fitlow/ Courtesy Rice University.

Rice University chemistry professor László Kürti was named as a recipient of the 2025 Ross M. Brown Investigator Award from the California Institute of Technology’s Brown Institute for Basic Sciences.

Kürti is one of eight mid-career faculty members to receive up to $2 million over five years for their research in the physical sciences.

“I’m greatly honored,” Kürti said in a news release. “We will learn a tremendous amount in the next five years and gain a much clearer understanding of the challenges ahead.”

Kürti was selected for the research he’s been developing for six years on a molecule called tetrahedral N4, which studies show can release large amounts of energy on demand. The molecule can also decompose directly into nitrogen gas without producing carbon dioxide or water vapor. Kürti believes N4 can be used as a "new type of fuel for vehicles."

“Eventually, N4 and other stable, neutral polynitrogen cages could be used to power rockets, helping us reach the moon or Mars faster and with heavier payloads,” he added in this release.

The Brown Investigator Awards were founded by entrepreneur and Caltech alumnus Ross M. Brown and established by the Brown Science Foundation in 2020. The organization has recognized 21 scientists over the last five years.

“Midcareer faculty are at a time in their careers when they are poised and prepared to make profound contributions to their fields,” Brown said in the news release. “My continuing hope is that the resources provided by the Brown Investigator Awards will allow them to pursue riskier innovative ideas that extend beyond their existing research efforts and align with new or developing passions, especially during this time of funding uncertainty.”

Trending News

A View From HETI

Cemvita has named a new leader in Brazil. Photo via cemvita.com

Houston industrial biotech company Cemvita has announced two strategic moves to advance its operations in Brazil.

The company, which utilizes synthetic biology to transform carbon emissions into valuable bio-based chemicals, acquired a complementary technology that expands its IP and execution of scale-up capacity, according to a news release. The acquisition will bring additional synthetic biology toolsets that Cemvita believes will assist with compressing and commercializing timelines.

The company also appointed Luciano Zamberlan as vice president of operations based in Brazil.

Zamberlan will lead operational execution, site readiness and early commissioning activities in Brazil. He brings more than 20 years of experience in biotechnology to the role. He recently served as director of engineering at Raízen, Brazil’s largest ethanol producer and the world’s largest producer of sugarcane ethanol. At Raízen, he coordinated the implementation of four greenfield plants and oversaw operational teams and process optimization for second-generation ethanol (E2G) and biogas.

“I am very pleased to join Cemvita, a company at the forefront of transforming waste into valuable, sustainable resources,” Zamberlan said in the release. “My expertise in scaling-up innovation, coupled with my experience in structuring and commissioning greenfield industrial operations, is perfectly aligned with Cemvita's mission and I'm eager to bring my energy and drive to accelerate Cemvita's industrial performance and contribute for a circular future.”

Cemvita expanded to Brazil in January to help capitalize on the country’s progressive regulatory framework, including Brazil’s Fuel of the Future Law, enacted in 2024. The law mandates an increase in the biodiesel content of diesel fuel, starting from 15 percent in March and increasing to 20 percent by 2030. It also requires the adoption of Sustainable Aviation Fuel (SAF) and for domestic flights to reduce greenhouse gas emissions by 1 percent starting in 2027, growing to 10 percent reduction by 2037.

“These steps enable us to augment Brazil’s longstanding bioindustrial ecosystem with next-generation capabilities, reducing early commercialization risk and expanding optionality for future product platforms,” Marcio Silva, CTO of Cemvita, said in the news release. “Together, they strengthen our ability to move from proof-of-concept to industrial reality.”

Trending News